Swiss pharmaceutical giant Novartis has announced a $23 billion investment to expand its U.S. operations, a move following President Trump's recent pledge to impose significant tariffs on imported drugs.
Health and Human Services Secretary Robert F. Kennedy Jr. is pursuing major changes to federal health policy, focusing on two controversial areas: restricting the use of food stamps for sugary drinks and eliminating pharmaceutical advertising on television. These efforts are part of Kennedy’s broader “Make America Healthy Again” campaign and have already drawn sharp responses from both government agencies and powerful industry groups.
A statewide grand jury that convened in 2022 upon the request of Florida Governor Ron DeSantis (R) concluded that there is no evidence of criminal activity linked to the COVID-19 vaccines.
Robert F. Kennedy Jr., President-elect Donald Trump’s nominee for Secretary of Health and Human Services (HHS), is meeting with Senate Democrats on key health committees to discuss his nomination
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania regarding royalty payments for its COVID-19 vaccine.
President-elect Donald Trump’s transition team is unveiling the "Make America Healthy Again" (MAHA) initiative, spotlighting a lineup of bold reformers slated to lead the nation’s healthcare overhaul. Trump’s Cabinet picks are positioned to tackle bureaucracy, corruption, and America’s rising chronic disease rates, with a focus on transparency and competition.
(News) – Elon Musk, CEO of SpaceX, Tesla, and Twitter, made waves last week with his announcement of a new CBD product, MicroBio CBD Gummies, claiming it offers groundbreaking benefits for dementia. The reveal, made during a live broadcast, drew sharp criticism from News host Martha MacCallum, who accused Musk of breaching contracts and jeopardizing sponsorships.
Several of the senators set to vote on Robert F. Kennedy Jr.'s appointment to lead the Department of Health and Human Services (HHS) have received donations from pharmaceutical companies.
